The opposing roles of nitric oxide and cGMP in the age-associated decline in rat testicular steroidogenesis

Endocrinology. 2013 Oct;154(10):3914-24. doi: 10.1210/en.2013-1307. Epub 2013 Jul 24.

Abstract

The molecular mechanism of the aging-associated dysfunction of Leydig cells (LCs) is complex and poorly understood. In this study, we analyzed the contribution of nitric oxide (NO) and cGMP signaling to the age-dependent decline in LC function. Significant (>50%) decreases in serum, intratesticular, and LC androgens in aging rats (15-24 months) were accompanied by a proportional increase in NO production, an up-regulation of cGMP levels, and the expression of soluble guanylyl cyclase-1B and protein kinase G1 in LCs. In contrast, LC cAMP levels decreased with age, most likely reflecting the up-regulation of cAMP-specific phosphodiesterase expression. Moreover, the expression of genes encoding enzymes responsible for cholesterol transport and its conversion to T were reduced. Exposing LCs from aged animals to NO further increased cGMP levels and decreased cAMP and androgen production, whereas the addition of cell-permeable 8-bromoguanosine-cGMP alone had the opposite effect. In vivo inhibition of cGMP-specific phosphodiesterase-5 for 3 and 6 months in aged rats led to a partial restoration of androgens, NO, and cyclic nucleotide levels, as well as the expression of steroidogenic and NO/cGMP signaling genes. These results indicate that a progressive increase in NO production contributes to the age-dependent decrease in steroidogenesis in a cGMP-independent manner, whereas the sustained elevation in cGMP levels significantly slows the decline in LC function.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging*
  • Androgens / blood
  • Androgens / metabolism*
  • Animals
  • Cells, Cultured
  • Cyclic AMP / metabolism*
  • Cyclic GMP-Dependent Protein Kinase Type I / biosynthesis
  • Cyclic GMP-Dependent Protein Kinase Type I / genetics
  • Cyclic GMP-Dependent Protein Kinase Type I / metabolism
  • Cyclic Nucleotide Phosphodiesterases, Type 5 / chemistry
  • Cyclic Nucleotide Phosphodiesterases, Type 5 / metabolism
  • Fertility Agents, Male / pharmacology
  • Gene Expression Regulation, Developmental / drug effects
  • Guanylate Cyclase / biosynthesis
  • Guanylate Cyclase / genetics
  • Guanylate Cyclase / metabolism
  • Leydig Cells / cytology
  • Leydig Cells / drug effects
  • Leydig Cells / metabolism*
  • Male
  • Nitric Oxide / metabolism*
  • Phosphodiesterase 5 Inhibitors / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Cytoplasmic and Nuclear / biosynthesis
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Second Messenger Systems* / drug effects
  • Soluble Guanylyl Cyclase
  • Testis / cytology
  • Testis / drug effects
  • Testis / growth & development
  • Testis / metabolism*
  • Up-Regulation

Substances

  • Androgens
  • Fertility Agents, Male
  • Phosphodiesterase 5 Inhibitors
  • Receptors, Cytoplasmic and Nuclear
  • Nitric Oxide
  • Cyclic AMP
  • Cyclic GMP-Dependent Protein Kinase Type I
  • Prkg1 protein, rat
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Pde5a protein, mouse
  • Guanylate Cyclase
  • Soluble Guanylyl Cyclase